ArticleHaematologica2026

Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party KMMWP-174 study.

Jung Yeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.